nebulizer

(redirected from nebulised)
Also found in: Dictionary, Thesaurus, Encyclopedia.
Related to nebulised: nebulize, jet nebulizer

nebulizer

 [neb´u-līz″er]
a device for dispensing liquid in a fine spray; types used include jet and ultrasonic nebulizers. Called also atomizer.
small volume nebulizer a pneumatically powered device used to aerosolize medications for delivery to patients.
ultrasonic nebulizer an electronic device that generates ultrasound waves that break up water into an aerosol mist.
Venturi nebulizer a type of nebulizer used in aerosol therapy. The pressure drop of gas flowing through the venturi mask draws liquid from a capillary tube; as the liquid enters the gas stream it breaks up into a spray of small droplets.

neb·u·liz·er

(neb'yū-līz'ĕr),
A device used to reduce a liquid medication to extremely fine cloudlike particles; useful in delivering medication to deeper parts of the respiratory tract.
See also: atomizer, vaporizer.

nebulizer

/neb·u·liz·er/ (neb´u-li″zer) atomizer; a device for throwing a spray.

nebulizer

[neb′yəlī′zər]
a device for producing a fine spray. Intranasal medications are often administered by a nebulizer. Also called atomizer.
enlarge picture
Nebulizer

nebulizer

Medtalk A device that converts aqueous solutions containing medications into fine–±10 µm in diameter droplets, which is small enough to pass directly to the alveoli

neb·u·liz·er

(neb'yū-lī-zĕr)
A device used to disperse liquid medicine in a mist of extremely fine particles; useful in delivering medicine to the lower respiratory tract; used in biowarfare to disperse toxins or other harmful biologic agents.
See also: atomizer, vaporizer

nebulizer

(neb'u-li?zer) [L. nebula, mist]
Enlarge picture
NEBULIZER
An apparatus for producing a fine spray or mist. This may be done by rapidly passing air through a liquid or by vibrating a liquid at a high frequency so that the particles produced are extremely small. See: aerosol; atomizer; vaporizer; illustration

ultrasonic nebulizer

An aerosol produced by the action of a vibrating ultrasonic transducer under water.
illustration

nebulizer

A form of inhaler used mainly in the control and treatment of ASTHMA. Nebulizers deliver an aerosol of the active drug in water or other vehicle. Some are electrically operated.

Nebulizer

A device that turns liquid forms of medicine into a fine spray that can be inhaled.

neb·u·liz·er

(neb'yū-lī-zĕr)
A device used to reduce a liquid medication to extremely fine cloudlike particles.

nebulizer

an atomizer; a device for creating an aerosol.
References in periodicals archive ?
Just 25 patients with cystic fibrosis are being prescribed nebulised tobramycin but another 30 could benefit from the treatment, as they meet the clinical criteria.
PPL recently announced (16 August 2000) a collaboration with Bayer to develop nebulised AAT treatments for AAT deficient patients and CF patients.
has marketed the nebulised version of colistimethate sodium (Colomycin([R])) for use in cystic fibrosis patients for over 20 years.
As reported on 29 September 2015, Phase IIa results from a prior study using nebulised RPL554 alone in stable COPD patients with moderate severity of disease, showed that, in addition to good tolerability and safety profile, RPL554 caused a pronounced improvement in lung function, as measured by peak FEV1, suggesting the drug produced a clinically meaningful bronchodilator effect.
One of the studies will take place in Germany, with a nebulised formulation of DX-890 to evaluate the reduction of the concentration of surrogate markers of inflammation, using broncho alvealoar lavage (BAL) as a means of measuring effect.
This study uses a new proprietary and commercially scalable nebulised suspension formulation of the Company's lead pipeline drug, RPL554.
In summary, the results confirm the good tolerability and the expected pharmacological effect of DX-890 on inhibition of neutrophil elastase in the lungs of CF patients when given as a nebulised formulation.
First asthma patients dosed with RPL554 in new proprietary nebulised formulation
L), the drug development company focused on first-in-class medicines to treat respiratory diseases, today announces the successful completion of the second phase of a Multiple Ascending Dose (MAD) study in which nebulised RPL554, a novel dual PDE3/PDE4 inhibitor, was administered to healthy subjects for up to five consecutive days at doses up to 16x larger than the previously used active dose.
inhibitor, which is currently in development as a nebulised treatment
been successfully dosed with a new proprietary, nebulised formulation of
currently in phase II development as a nebulised treatment for acute